Signaling Pathways - PKA - MET - Cholangiocarcinoma - Cancer
清除全部
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR2抑制剂
- A8616 A-674563Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSKSummary: Akt1 / PKA / CDK2的强效选择性抑制剂
- A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met(野生型/突变型)抑制剂
- A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met抑制剂
- A5703 BMS-777607Target: METSummary: 强效的c-Met选择性抑制剂
- A5653 AT7867Target: Akt|PKA|p70 rskSummary: Akt1/2/3和p70S6K/PKA的抑制剂
- A5072 GSK690693Target: Akt|PKC|PKG|PKA|PrkSummary: ATP竞争性的Pan-AKT抑制剂
- A1196 SGX-5231 CitationTarget: METSummary: 高度选择性的、ATP竞争性的Met抑制剂